Need help finding what you are looking for?
Contact Us
PUBLISHER: The Business Research Company | PRODUCT CODE: 2104682
PUBLISHER: The Business Research Company | PRODUCT CODE: 2104682
Lung Cancer Liquid Biopsy Global Market Opportunities And Strategies To 2035
PUBLISHED:
PAGES: 373 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Lung cancer liquid biopsy refers to a minimally invasive diagnostic approach used to detect and monitor lung cancer by analyzing tumor-derived materials, such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs) and other biomarkers, in bodily fluids, primarily blood. This market encompasses the revenues generated by entities, including biotechnology companies, diagnostic laboratories and healthcare institutions, that develop and provide liquid biopsy-based products and services for lung cancer diagnosis and management. These tests are used by oncologists, pathologists and healthcare providers for patients suspected of having lung cancer, as well as those undergoing treatment or post-treatment surveillance.
The lung cancer liquid biopsy market consists of sales by entities (organizations, sole traders and partnerships) that provide products and services for the detection and management of lung cancer using liquid biopsy. This includes instruments, consumables, kits and reagents, as well as software and related services. These solutions support various stages such as sample collection and processing, assay development and testing, data analysis and interpretation and clinical decision support and are based on technologies such as next-generation sequencing (NGS) and polymerase chain reaction (PCR).
The global lung cancer liquid biopsy market was valued at $361.9 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 25.00%.
High Prevalence Of Smoking And Tobacco Consumption
During historic period, high prevalence of smoking and tobacco consumption supported the growth of the lung cancer liquid biopsy market. Widespread tobacco use increased the incidence of lung cancer, creating a strong demand for efficient and early diagnostic solutions. Healthcare providers increasingly turned to liquid biopsy technologies as a non-invasive method for detecting and monitoring cancer, particularly among high-risk populations such as long-term smokers. Additionally, rising awareness of smoking-related health risks encouraged more individuals to undergo screening. For instance, in November 2025, according to the OECD (Organization for Economic Co-operation and Development), a France-based intergovernmental international organization, 14.8% of people aged 15 and over smoked daily in 2023. The proportion of daily smokers was highest in Turkiye, Hungary and Greece, as well as in accession/partner countries Indonesia, Bulgaria and China, where at least one in four people smoked daily. On average, 18.5% of men smoked daily in 2023 compared to 11.4% of women. Therefore, high prevalence of smoking and tobacco consumption drove the growth of the lung cancer liquid biopsy market.
Advancing ctDNA-Guided Adaptive Immunotherapy For Real-Time Cancer Treatment Optimization
Key players operating in the lung cancer liquid biopsy market are advancing circulating tumor DNA (ctDNA)-driven precision oncology solutions, enabling real-time treatment monitoring, adaptive immunotherapy strategies and improved patient stratification to enhance clinical outcomes and personalized cancer care. For instance, in December 2025, Cancer Research Institute, a US-based biotechnology company, has initiated the next phase of its BR.36 Phase 2/3 clinical trial, leveraging liquid biopsy technology from Labcorp Holdings Inc., a US-based healthcare company, to guide precision immunotherapy for advanced lung cancer. The study uses circulating tumor DNA (ctDNA) to monitor early responses to treatment and adapt therapy accordingly. Patients showing high risk of disease progression may receive a combination of immunotherapy and chemotherapy, improving personalized care strategies. Led by leading research institutions including Johns Hopkins Kimmel Cancer Center, the trial aims to enhance treatment outcomes and establish ctDNA as a key tool in real-time cancer management.
The global lung cancer liquid biopsy market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 28.08% of the total market in 2024.
Lung Cancer Liquid Biopsy Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global lung cancer liquid biopsy market.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is evolving with growth in the number of listed companies, greater focus on ESG and sustainability positioning, increased focus on broadening shareholder base and rising frequency of M&A and corporate restructuring.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for lung cancer liquid biopsy? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The lung cancer liquid biopsy market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider lung cancer liquid biopsy market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis And Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth: - Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis: - Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation: - Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by product, by technology, by biomarker, by clinical application and by end user in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size And Growth: - Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard: - Briefs on competitive dashboard of major players.
- Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments: - Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies: Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations: This section includes recommendations for lung cancer liquid biopsy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Product: Instruments; Consumables, Kits And Reagents; Software And Services
- 2) By Technology: Multi-Gene-Parallel Analysis (NGS); Single-Gene Analysis (PCR Microarrays)
- 3) By Biomarker: Circulating Tumor Deoxyribonucleic Acid; Extracellular Vesicles; Circulating Tumor Cells; Other Biomarkers
- 4) By Clinical Application: Therapy Selection; Treatment Monitoring; Early Cancer Screening; Recurrence Monitoring; Other Applications
- 5) By End User: Diagnostics And Imaging Centers; Hospitals; Academics And Research Centers; Other End Users
- Companies Mentioned: F. Hoffmann-La Roche Ltd; QIAGEN NV; Guardant Health Inc; Thermo Fisher Scientific Inc; Eurofins Scientific SE
- Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Canada; Mexico; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; lung cancer liquid biopsy indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: HS5MLCLB01_O26Q1
Table of Contents
1 Executive Summary
- 1.1 Dashboard
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 Lung Cancer Liquid Biopsy Market Definition And Segmentations
- 6.4 Market Segmentation By Product (Instruments, Consumables, Kits And Reagents, Software And Services)
- 6.5 Market Segmentation By Technology (Multi-Gene-Parallel Analysis (NGS) And Single-Gene Analysis (PCR Microarrays))
- 6.6 Market Segmentation By Biomarker (Circulating Tumor Deoxyribonucleic Acid, Extracellular Vesicles, Circulating Tumor Cells And Other Biomarkers)
- 6.7 Market Segmentation By Clinical Application (Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring And Other Applications)
- 6.8 Market Segmentation By End User (Diagnostics And Imaging Centers, Hospitals, Academics And Research Centers And Other End Users)
7 Lung Cancer Liquid Biopsy Market, Overview Of Key Products/Services
8 Global Lung Cancer Liquid Biopsy Market Attractiveness Scoring And Analysis
- 8.1 Overview Of Market Attractiveness Framework
- 8.2 Quantitative Scoring Methodology
- 8.3 Market Attractiveness Scoring And Interpretation
- 8.4 Factor-Wise Evaluation
- 8.4.1 Growth Potential
- 8.4.2 Competitive Dynamics
- 8.4.3 Strategic Fit
- 8.4.4 Risk Profile
- 8.5 Strategic Implications And Recommendations
- 8.5.1 Strategic Implications
- 8.5.2 Strategic Recommendations
9 Lung Cancer Liquid Biopsy Market, Supply Chain Analysis
- 9.1 Overview of the Supply Chain and Ecosystem
- 9.1.1 Resources
- 9.1.2 Manufacturers
- 9.1.3 Distribution
- 9.1.4 End Users
10 Major Market Trends
- 10.1 Key Technologies & Future Trends
- 10.1.1 Biotechnology, Genomics And Precision Medicine
- 10.1.2 Artificial Intelligence And Autonomous Intelligence
- 10.1.3 Digitalization, Cloud, Big Data And Cybersecurity
- 10.1.4 Industry 4.0 And Intelligent Manufacturing
- 10.2 Major Trends
- 10.2.1 Advancing ctDNA-Guided Adaptive Immunotherapy For Real-Time Cancer Treatment Optimization
- 10.2.2 Rising Focus on AI-Integrated Multi-Omics for Minimal Residual Disease Detection and Recurrence Monitoring
- 10.2.3 Strategic Focus on AI-Driven Early Detection and Fragmentomics-Based Liquid Biopsy Innovations
11 Global Lung Cancer Liquid Biopsy Growth Analysis And Strategic Analysis Framework
- 11.1 Global Lung Cancer Liquid Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 11.1.1 Political
- 11.1.2 Economic
- 11.1.3 Social
- 11.1.4 Technological
- 11.1.5 Environmental
- 11.1.6 Legal
- 11.2 End User (B2B) Analysis
- 11.2.1 Diagnostics And Imaging Centers
- 11.2.2 Hospitals
- 11.2.3 Academics And Research Centers
- 11.2.4 Other End Users
12 Global Lung Cancer Liquid Biopsy Market Size And Growth Analysis
- 12.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
- 12.1.1 Market Drivers 2020 - 2025
- 12.1.2 Market Restraints 2020 - 2025
- 12.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
- 12.3 Forecast Growth Contributors/Factors
- 12.3.1 Quantitative Growth Contributors
- 12.3.2 Drivers
- 12.3.3 Restraints
13 Global Lung Cancer Liquid Biopsy Total Addressable Market (TAM) Analysis
- 13.1 Definition And Scope of Total Addressable Market (TAM)
- 13.2 Methodology And Assumptions
- 13.2.1 Total Addressable Market for the Lung Cancer Liquid Biopsy Market - Business to Business (B2B)
- 13.2.2 TAM Comparison Analysis
14 Global Lung Cancer Liquid Biopsy Market Segmentation
- 14.1 Global Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.2 Global Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.3 Global Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.4 Global Lung Cancer Liquid Biopsy Market, Segmentation By Clinical Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.5 Global Lung Cancer Liquid Biopsy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.6 Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.7 Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables, Kits And Reagents, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.8 Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Software And Services, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15 Lung Cancer Liquid Biopsy Market, Regional and Country Analysis
- 15.1 Global Lung Cancer Liquid Biopsy Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.2 Global Lung Cancer Liquid Biopsy Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
16 Asia-Pacific Market
- 16.1 Asia-Pacific Market Summary
- 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 16.3 Asia-Pacific Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.4 Asia-Pacific Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.5 Asia-Pacific Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.6 China Market
- 16.6.1 China Market Summary
- 16.6.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 16.6.3 China Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.6.4 China Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.6.5 China Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.7 India Market
- 16.7.1 India Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.7.2 India Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.7.3 India Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.8 Japan Market
- 16.8.1 Japan Market Summary
- 16.8.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 16.8.3 Japan Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.8.4 Japan Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.8.5 Japan Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.9 Australia Market
- 16.9.1 Australia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.9.2 Australia Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.9.3 Australia Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.10 South Korea Market
- 16.10.1 South Korea Market Summary
- 16.10.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 16.10.3 South Korea Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.10.4 South Korea Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.10.5 South Korea Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.11 Taiwan Market
- 16.11.1 Taiwan Market Summary
- 16.11.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 16.11.3 Taiwan Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.11.4 Taiwan Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.11.5 Taiwan Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
17 South East Asia Market
- 17.1 South East Asia Market Summary
- 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 17.2.1 South East Asia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.2.2 South East Asia Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.2.3 South East Asia Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.3 Indonesia Market
- 17.3.1 Indonesia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.3.2 Indonesia Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.3.3 Indonesia Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
18 North America Market
- 18.1 North America Market Summary
- 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 18.3 North America Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.4 North America Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.5 North America Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.6 USA Market
- 18.6.1 USA Market Summary
- 18.6.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 18.6.3 USA Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.6.4 USA Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.6.5 USA Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.7 Canada Market
- 18.7.1 Canada Market Summary
- 18.7.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 18.7.3 Canada Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.7.4 Canada Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.7.5 Canada Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
19 Western Europe Market
- 19.1 Western Europe Market Summary
- 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 19.3 Western Europe Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.4 Western Europe Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.5 Western Europe Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.6 UK Market
- 19.6.1 UK Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.6.2 UK Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.6.3 UK Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.7 Germany Market
- 19.7.1 Germany Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.7.2 Germany Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.7.3 Germany Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.8 France Market
- 19.8.1 France Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.8.2 France Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.8.3 France Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.9 Italy Market
- 19.9.1 Italy Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.9.2 Italy Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.9.3 Italy Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.10 Spain Market
- 19.10.1 Spain Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.10.2 Spain Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.10.3 Spain Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
20 South America Market
- 20.1 South America Market Summary
- 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
- 20.3 South America Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.4 South America Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.5 South America Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.6 Brazil Market
- 20.6.1 Brazil Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.6.2 Brazil Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.6.3 Brazil Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
21 Eastern Europe Market
- 21.1 Eastern Europe Market Summary
- 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
- 21.3 Eastern Europe Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 21.4 Eastern Europe Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 21.5 Eastern Europe Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 21.6 Russia Market
- 21.6.1 Russia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 21.6.2 Russia Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 21.6.3 Russia Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
22 Middle East Market
- 22.1 Middle East Market Summary
- 22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 22.3 Middle East Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 22.4 Middle East Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 22.5 Middle East Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
23 Africa Market
- 23.1 Africa Market Summary
- 23.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
- 23.3 Africa Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 23.4 Africa Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 23.5 Africa Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
24 Competitive Landscape And Company Profiles
- 24.1 Lung Cancer Liquid Biopsy Market Competitive Landscape And Market Share 2024
- 24.1.1 Top 10 Companies (Ranked by revenue/share)
- 24.2 Company Profiles
- 24.3 F. Hoffmann-La Roche Ltd (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 24.4 Qiagen N.V. (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 24.5 Guardant Health Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 24.6 Thermo Fisher Scientific Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 24.7 Eurofins Scientific SE (Company Overview, Products and Services, Business Strategy, Financial Overview)
25 Other Major And Innovative Companies
- 25.1 NeoGenomics Laboratories Inc. (Company Overview | Products and Services)
- 25.2 Agilent Technologies Inc. (Company Overview | Products and Services)
- 25.3 Sysmex Corporation (Company Overview | Products and Services)
- 25.4 Illumina Inc. (Company Overview | Products and Services)
- 25.5 Biodesix Inc. (Company Overview | Products and Services)
- 25.6 SOPHiA GENETICS SA (Company Overview | Products and Services)
- 25.7 Caris Life Sciences Inc. (Company Overview | Products and Services)
- 25.8 Natera Inc. (Company Overview | Products and Services)
- 25.9 Bio-Rad Laboratories Inc. (Company Overview | Products and Services)
- 25.10 MDxHealth SA (Company Overview | Products and Services)
- 25.11 Foresight Diagnostics Inc. (Company Overview | Products and Services)
- 25.12 Myriad Genetics Inc. (Company Overview | Products and Services)
- 25.13 Menarini Silicon Biosystems Inc. (Company Overview | Products and Services)
- 25.14 Inivata Ltd. (Company Overview | Products and Services)
- 25.15 LungLife AI Inc. (Company Overview | Products and Services)
26 Competitive Benchmarking
27 Competitive Dashboard
28 Lung Cancer Liquid Biopsy Market - Company Scoring Matrix
- 28.1 Innovation & Brand Leaders
- 28.2 Brand-Driven Traditionalists
- 28.3 Niche or Regional Followers
- 28.4 Emerging Innovators
29 Upcoming Startups In the Lung Cancer Liquid Biopsy Market
30 Key Mergers And Acquisitions
- 30.1 Abbott Laboratories Acquired Exact Sciences Corporation
- 30.2 Veracyte Inc Acquired C2i Genomics Inc
- 30.3 Quest Diagnostics Acquired Haystack Oncology
31 Recent Developments In Lung Cancer Liquid Biopsy
- 31.1 Strengthening Precision Oncology Through Advanced Liquid Biopsy Integration In Clinical Research
- 31.2 Development Of Updated Platforms To Provide Advanced Cancer Profiling
32 Opportunities And Strategies
- 32.1 Global Lung Cancer Liquid Biopsy Market In 2030 - Countries Offering Most New Opportunities
- 32.2 Global Lung Cancer Liquid Biopsy Market In 2030 - Segments Offering Most New Opportunities
- 32.3 Global Lung Cancer Liquid Biopsy Market In 2030 - Growth Strategies
- 32.3.1 Market Trend Based Strategies
- 32.3.2 Competitor Strategies
33 Lung Cancer Liquid Biopsy Market, Conclusions And Recommendations
- 33.1 Conclusions
- 33.2 Recommendations
- 33.2.1 Product
- 33.2.2 Place
- 33.2.3 Price
- 33.2.4 Promotion
- 33.2.5 People
34 Appendix
- 34.1 Geographies Covered
- 34.2 Market Data Sources
- 34.3 Research Methodology
- 34.4 Currencies
- 34.5 The Business Research Company
- 34.6 Copyright and Disclaimer
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.